ArticleWorld journal of clinical cases2020

Can cyclin-dependent kinase 4/6 inhibitors convert inoperable breast cancer relapse to operability? A case report.

Michela Palleschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.